Mr. Yusuke Honjo of Nobel Prize in Medicine and Physiology to file a lawsuit against Ono Pharmaceutical Co., Ltd. 20:12 on June 5

Nobel Laureate in Medicine and Physiology and special professor at Kyoto University, Yusuke Honjo, pays over 22.6 billion yen in cooperation to Ono Pharmaceutical Co., Ltd. in Osaka, which manufactures and sells cancer treatment drugs that he was involved in developing. Has announced that it will file a lawsuit against the court in the middle of this month.

This was revealed on the 5th by Mr. Honjo holding a press conference with lawyers and university officials.

As a result, Mr. Honjo was the president of Ono Yakuhin Kogyo at the time of a patent infringement lawsuit in dispute with an American pharmaceutical company regarding the drug "OPDIVO" that was developed jointly with Ono Yakuhin Kogyo to treat cancer with the power of immunity. It means that there was a request from us to cooperate.

Ono Pharmaceutical Co., Ltd. settled in a trial, and according to Mr. Honjo and others, the company decided to pay 40% of the amount obtained as a result of the trial, but actually only 1% was paid.

Mr. Honjo is planning to file a lawsuit in the Osaka District Court in the middle of this month requesting payment of the unpaid amount of 22.6 billion yen.

Mr. Honjo wants to consider whether he will also make an appeal for the revision of contracts etc. to increase the distribution of patent fees for drugs linked with Ono Pharmaceutical Co., Ltd.

Mr. Honjo said, "In Japan, there are frequent problems that companies can abuse the ignorance of researchers to make very unilateral contracts. I want people to appreciate the value of intellectual activities." I am.

Ono Pharmaceutical "I want to refrain from commenting"

Ono Pharmaceutical Co., Ltd. said, "I do not understand the content of the interview, so I would like to refrain from commenting."

Kyoto University “Judgment of further jurisdiction leading to further knowledge”

Mr. Honjo said that he has filed a lawsuit against Ono Pharmaceutical Co., Ltd. It is extremely important as a result of research activities at this university, and also important as a successful example of industry-academia collaboration activities. I want to expect a judicial decision that will lead to.”